Medvest Capital
Venture capitalPalm Beach Gardens · Pre-Seed–Late Stage · 3 people tracked
Investment thesis
Medvest Capital is a mission-driven venture firm focused on early-stage medical device companies. Its investment approach centers on three interrelated principles: improving patient outcomes, decreasing delivery costs, and minimizing provider risk. Beyond capital, the firm works closely with portfolio company management to validate market feasibility, fast-track product development, and establish the business processes needed for sustainable growth. Target investments range from $1 million to $3 million.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website & public directoriesWhat they invest in
from 3 of 7 portfolio companiesBiotech ×2Healthtech ×2Medical Devices ×2Deep Tech ×1Digital Health ×1Hardware ×1Mental Health ×1
HQs:United States×3
Investments · 7 tracked
founders shown can be your intro path
BrightSpec develops molecular rotational resonance (MRR) spectroscopy instruments and software that identify and quantify gas-phase molecules from complex mixtures without front-end separation.
BiotechDeep TechHardwareWaltham, US
Rick Gordon(CEO)inWalter Colsman(Executive Officer, Director)JAFFRAY WOODRIFF(Director)ROBERT LLOYD(Executive Officer, Director)THOMAS JONES(Director)DAVID MCDANIEL(Executive Officer, Director)
Co-investorsArboretum VenturesGenoa Ventures
Freespira develops an FDA-indicated medical device combined with clinical support for treating PTSD and panic disorder symptoms at home over 28 days.
Digital HealthHealthtechMedical DevicesMental Health
Co-investorsAphelion CapitalLightspeed Venture Partners
Mercator MedSystems develops catheter-based Micro-Infusion technologies, including the Bullfrog Micro-Infusion Device, for the local delivery of pharmacologic and biologic agents to the peripheral vasculature.
BiotechHealthtechMedical DevicesSan Leandro, US
Kirk P. Seward(Co-founder, President and CEO)inTrent Reutiman(Executive Officer, Director)Stephen Baker(Executive Officer)Kirk Seward(Executive Officer)Charles Crocker(Director)Doug Wall(Director)
Co-investorsAphelion Capital
Walnut Creek, US
Jeffrey D. Smith(Executive Officer, Director)Bruce M. McCormack, MD(Executive Officer, Director)Evan Ng(Executive Officer)
BoardDavid Cash(Director)inJames Hens(Director)Arthur T. Taylor(Director)
Co-investorsAphelion Capital
Frequently asked questions
- How many investments has Medvest Capital made?
- Medvest Capital has 7 tracked investments.
- What stage does Medvest Capital invest at?
- Medvest Capital invests at the Pre-Seed, Seed, Series A, Late Stage stages.
- What is Medvest Capital's typical check size?
- Medvest Capital typically writes checks of $1M – $3M.
- What sectors does Medvest Capital focus on?
- Medvest Capital focuses on Healthtech, Medical Devices.
- Where is Medvest Capital located?
- Medvest Capital is headquartered in Palm Beach Gardens, US.
- Who does Medvest Capital co-invest with?
- Medvest Capital most often shares deals with Aphelion Capital, Arboretum Ventures, Genoa Ventures, among 4 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
RiverVest Venture Partners is a life sciences venture capital firm that invests in biotechnology and medical companies, working with entrepreneurs to advance therapeutic and medical innovations.
SMBC Venture Capital is a Japanese venture capital firm and a member of Sumitomo Mitsui Financial Group (SMBC Group), with over 20 years of investing experience. It leverages the group's network of auditors, securities firms, and other investors to support startups.